Swedbank Ab Insmed Inc Transaction History

Swedbank Ab

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Dec 09, 2024	SELL	$23.42 - $31.74 $1.75 Million - $2.37 Million	-74,557 Closed	0 $0
Q3 2023 Dec 09, 2024	SELL	$19.86 - $26.93 $357,480 - $484,740	-18,000 Reduced 19.45%	74,557 $1.88 Million
Q2 2023 Dec 09, 2024	SELL	$16.44 - $21.1 $471,828 - $605,570	-28,700 Reduced 23.67%	92,557 $1.95 Million
Q1 2022 Dec 09, 2024	BUY	$20.42 - $28.13 $391,185 - $538,886	19,157 Added 18.76%	121,257 $2.85 Million
Q1 2021 Dec 09, 2024	BUY	$32.28 - $44.3 $3.3 Million - $4.52 Million	102,100 New	102,100 $3.48 Million

467

182M

2.27M

3.33M

Ticker INSM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 135,476,992
Market Cap $10.1B
Description
Insmed Incorporated, a biopharmaceutical company, develops and commercializes therapies for patients with serious and rare diseases. The company offers ARIKAYCE for the treatment of Mycobacterium avium complex lung disease as part of a combination antibacterial drug regimen for adult patients. It is also developing Brensocatib, an oral reversibl...

Get notified when there are updates to the investment portfolio of Swedbank Ab, based on Form 13F filings with the SEC.

Stay updated on Swedbank Ab with notifications on news.